Nuvectis Pharma, Inc. - COM (NVCT)

CUSIP: 67080T108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COM
Total 13F shares
3,242,656
Share change
+1,179,487
Total reported value
$24,212,274
Put/Call ratio
113%
Price per share
$7.47
Number of holders
46
Value change
+$8,414,990
Number of buys
34
Number of sells
14

Security key

67080T108

Report period

Q2 2025

Institutions

46

Top holders

10

Top shareholders of NVCT - Nuvectis Pharma, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
class O/S missing
467,419
$4,566,684 31 Mar 2025
13F
BALDWIN WEALTH PARTNERS LLC/MA
13F
Company
class O/S missing
358,461
$3,502,164 31 Mar 2025
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
class O/S missing
253,972
$2,481,306 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
135,333
$1,323,052 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
class O/S missing
121,101
$1,183,157 31 Mar 2025
13F
Kenneth Hoberman
3/4/5
Director
class O/S missing
133,140
$1,122,370 12 Jun 2025
UBS Group AG
13F
Company
class O/S missing
111,520
$1,089,550 31 Mar 2025
13F
James F. Oliviero III
3/4/5
Director
class O/S missing
87,828
$740,390 12 Jun 2025
BlackRock, Inc.
13F
Company
class O/S missing
68,484
$669,088 31 Mar 2025
13F
FORBES J M & CO LLP
13F
Company
class O/S missing
59,000
$576,430 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
class O/S missing
45,608
$445,590 31 Mar 2025
13F
Austin Wealth Management, LLC
13F
Company
class O/S missing
40,250
$441,140 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
class O/S missing
42,299
$413,261 31 Mar 2025
13F
OPPENHEIMER & CO INC
13F
Company
class O/S missing
41,000
$400,570 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
class O/S missing
38,874
$379,799 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
38,058
$371,827 31 Mar 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
class O/S missing
34,751
$340,000 31 Mar 2025
13F
OMERS ADMINISTRATION Corp
13F
Company
class O/S missing
32,882
$321,257 31 Mar 2025
13F
Uri Ben-Or
3/4/5
Int. Principal Financial Off.
class O/S missing
25,584
$283,471 08 Feb 2022
STATE STREET CORP
13F
Company
class O/S missing
27,750
$271,118 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
class O/S missing
20,093
$196,309 31 Mar 2025
13F
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
class O/S missing
15,170
$148,211 31 Mar 2025
13F
BAXTER BROS INC
13F
Company
class O/S missing
15,000
$146,550 31 Mar 2025
13F
NATIONS FINANCIAL GROUP INC, /IA/ /ADV
13F
Company
class O/S missing
13,500
$131,895 31 Mar 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
class O/S missing
13,483
$131,729 31 Mar 2025
13F
Squarepoint Ops LLC
13F
Company
class O/S missing
11,012
$107,587 31 Mar 2025
13F
Blue Zone Wealth Advisors, LLC
13F
Company
class O/S missing
10,424
$101,842 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
10,344
$101,061 31 Mar 2025
13F
Jain Global LLC
13F
Company
class O/S missing
10,154
$99,205 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
class O/S missing
6,977
$68,165 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
1,656
$16,179 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
class O/S missing
1,159
$11,324 31 Mar 2025
13F
CITIGROUP INC
13F
Company
class O/S missing
1,025
$10,014 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
179
$1,749 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
102
$997 31 Mar 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
class O/S missing
100
$977 31 Mar 2025
13F

Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2025

As of 30 Jun 2025, Nuvectis Pharma, Inc. - COM (NVCT) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,242,656 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., IRIDIAN ASSET MANAGEMENT LLC/CT, BALDWIN WEALTH PARTNERS LLC/MA, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, OPPENHEIMER & CO INC, MARSHALL WACE, LLP, and FORBES J M & CO LLP. This page lists 46 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
33
Q2 2025 holders
46
Holder diff
13
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .